Skip to content

Sound Acupuncture in Painful Chemotherapy-Related Neuropathies

Effectiveness of Sound Acupuncture in Painful Chemotherapy-Related Neuropathies: A Non-Invasive Alternative to Acupuncture? Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07187986
Acronym
SUONO-PT 01
Enrollment
40
Registered
2025-09-23
Start date
2022-03-17
Completion date
2025-07-16
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathic Pain in Cancer

Brief summary

The objective of this clinical trial is to evaluate the efficacy of sound acupuncture in combination with traditional medical therapy in the treatment of chemotherapy-induced peripheral neuropathies. Sound acupuncture is a non-invasive technique that involves stimulating energy points, used in acupuncture, with the help of specific tuning forks and the frequencies they emit. The energy points are those used in Chinese medicine and, more specifically, in acupuncture. The aim is to restore the recipient's complex bioenergetic system to an optimal state of well-being and balance Participants: 20 patients will receive only the best medical therapy; 20 patients will receive BMT and sound acupuncture treatment

Interventions

OTHERSound acupuncture

Best medical therapy + soundpuncture

Sponsors

Ente Ospedaliero Ospedali Galliera
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 30-80 years * Clinical and electrophysiological diagnosis of chemotherapy-induced neuropathy * Patients being treated with Best Medical Therapy for neuropathic pain * Written informed consent

Exclusion criteria

* Women who are pregnant or breastfeeding * Patients with intellectual disabilities or cognitive impairment that impair their ability to comply with the consent process * Pacemaker users

Design outcomes

Primary

MeasureTime frameDescription
Pain reduction1 yearAt least a 30% reduction from baseline on the NPS scale for neuropathic pain

Secondary

MeasureTime frameDescription
Back Depression inventory1 yearEffectiveness of sound therapy combined with pharmacological treatment through administration of the BDI-II scale
Quality of life assessment1 yearEQ-5D scale for assessing the impact on quality of life

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026